SpyGlass Pharma, Inc. Common Stock (SGP) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $32.00 (-1.57%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 3, 2026 | Dennis Ding | Jefferies | $62.00 | +93.8% |
Top Analysts Covering SGP
SGP vs Sector & Market
| Metric | SGP | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +18.8% | +153002.0% | +21.5% |
| P/E Ratio | 8.56 | 3.46 | 38.49 |
Frequently Asked Questions
What is the analyst consensus for SGP?
The consensus among 2 analysts covering SpyGlass Pharma, Inc. Common Stock (SGP) is Buy with an average price target of $38.00.
What is the highest price target for SGP?
The highest price target for SGP is $62.00, set by Dennis Ding at Jefferies on 2026-03-03.
What is the lowest price target for SGP?
The lowest price target for SGP is $62.00, set by Dennis Ding at Jefferies on 2026-03-03.
How many analysts cover SGP?
2 analysts have issued ratings for SpyGlass Pharma, Inc. Common Stock in the past 12 months.
Is SGP a buy or sell right now?
Based on 2 analyst ratings, SGP has a consensus rating of Buy (2.00/5) with a +18.8% upside to the consensus target of $38.00.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.